Clin2
NCT07177235Possibly a fitNot yet recruiting

Ketamine for seizures that won't stop

Refractory Status Epilepticus

Treatments studied

Part of Brain & nervous system clinical trials.

This study tests whether ketamine can help stop seizures that haven't responded to standard treatments. It's for people with a serious condition called status epilepticus, where seizures don't stop on their own.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • Your seizures did not stop after trying a first-line medicine like lorazepam, midazolam, or diazepam given through an IV.
  • Your seizures did not stop after also trying a second-line medicine like phenytoin, valproate, levetiracetam, or lacosamide.
  • You are not pregnant.
  • You do not have a condition where a rise in blood pressure would be dangerous.
  • Your seizures have not been going on for longer than 24 hours before enrollment.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05851391Recruiting· Phase 2
Test drug treatment to stop hard-to-control seizures after cardiac arrest

This Phase 2 trial tests a medication strategy to stop “refractory status epilepticus,” a severe seizure condition that can happen after a cardiac arrest. It may help by reducing ongoing seizure activity after return of circulation in the ICU.

San Francisco, California
NCT03223220Not yet recruiting· Phase 2/Phase 3
Ketamine for acute ischemic stroke

This trial tests whether a single dose of ketamine, given within 24 hours of a stroke, can reduce brain damage and improve recovery. It is designed for people who had a recent ischemic stroke and who are not eligible for standard clot-busting or clot-removal treatments.

Wynnewood, Pennsylvania
NCT06788249Recruiting· Early Phase 1
Ketamine for treatment-resistant depression brain study

This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.

Philadelphia, Pennsylvania
NCT07307768Not yet recruiting· Phase 1
Ketamine treatment study for severe major depression

This study tests how a single dose of ketamine affects certain brain and body markers in people with severe depression. It aims to find better ways to predict who will respond to ketamine, which may help personalize depression treatment in the future.

New York, New York
NCT06907173Recruiting· Phase 3
Ketamine for ongoing seizures in the ER

This trial tests if adding ketamine to standard care can stop seizures that continue after a first treatment. It is for people having a convulsive seizure lasting more than 5 minutes and who are still seizing in the emergency room.

Birmingham, Alabama
NCT07095842Recruiting· Phase 2/Phase 3
Early ketamine for kids with seizure emergencies

This trial tests if giving ketamine early, before reaching the hospital, can stop prolonged seizures in children with epilepsy. It is for kids who have had at least one seizure emergency in the past year.

Sohag

Hear when a new Refractory Status Epilepticus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.